Biologic on Par With OIT for Turning Allergy-Forbidden Foods Into Everyday Eats

(MedPage Today) — PHILADELPHIA — Most multi-food allergic children succeeded in longer term regular dietary consumption whether treated with oral immunotherapy (OIT) or omalizumab (Xolair) alone, results from stage 3 of the OUtMATCH trial showed…

Source link : https://www.medpagetoday.com/meetingcoverage/aaaai/120102

Author :

Publish date : 2026-03-01 19:21:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Biologic on Par With OIT for Turning Allergy-Forbidden Foods Into Everyday Eats

Substantial HIV Prevalence in U.S. Teens With Syphilis, but Cases Are Declining

‘The Situation Is Alarming’: What We Heard This Week

Related Posts

Study Looks at GLP-1 Use in Pregnancy and Gestational Weight Gain

Hospital Shootings Became More Common Over 25 Years

Regular Cannabis Use Linked to Symptoms of Menopause

Frailty, Not Age, Drives Risk With SGLT2, GLP-1 Meds

Home-Based Neuromodulator Shows Promise for Suppressing Ventricular Arrhythmias

Study Raises Questions About Effects, Risks of Drugs for Geographic Atrophy

Study Looks at GLP-1 Use in Pregnancy and Gestational Weight Gain

Hospital Shootings Became More Common Over 25 Years

Regular Cannabis Use Linked to Symptoms of Menopause

Frailty, Not Age, Drives Risk With SGLT2, GLP-1 Meds

Home-Based Neuromodulator Shows Promise for Suppressing Ventricular Arrhythmias

Study Raises Questions About Effects, Risks of Drugs for Geographic Atrophy

Sharp Drop in Bariatric Surgery; Plea to Protect Research; How to Prescribe Exercise

Brain Changes Tied to Single Psilocybin Dose; 50 Days to See Neurology; APOE4 and MS

Categories

Archives